相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Separation and identification of differentially expressed nuclear matrix proteins in breast carcinoma forming
Qian He et al.
ACTA ONCOLOGICA (2010)
Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue
Claudia Roewer et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2009)
Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast Cancer
Arzu Umar et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Clinical-translational strategies for the elevation of Nm23-H1 metastasis suppressor gene expression
Jean-Claude Marshall et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation
S. N. Brady et al.
ONCOGENE (2009)
Generally detected proteins in comparative proteomics - A matter of cellular stress response?
Ping Wang et al.
PROTEOMICS (2009)
MS characterization of apheresis samples from rheumatoid arthritis patients for the improvement of immunoadsorption therapy - a pilot study
Mike Kienbaum et al.
PROTEOMICS CLINICAL APPLICATIONS (2009)
Cancer Abolishes the Tissue Type-Specific Differences in the Phenotype of Energetic Metabolism
Paloma Acebo et al.
TRANSLATIONAL ONCOLOGY (2009)
Tissue proteomics for cancer biomarker development - Laser microdissection and 2D-DIGE -
Tadashi Kondo
BMB REPORTS (2008)
Advances in Breast Cancer: Pathways to Personalized Medicine
Olufunmilayo I. Olopade et al.
CLINICAL CANCER RESEARCH (2008)
Clinical-translational approaches to the Nm23-H1 metastasis suppressor
Patricia S. Steeg et al.
CLINICAL CANCER RESEARCH (2008)
Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer
Mitch Dowsett et al.
CLINICAL CANCER RESEARCH (2008)
Direct Interaction between NM23-H1 and Macrophage Migration Inhibitory Factor (MIF) Is Critical for Alleviation of MIF-mediated Suppression of p53 Activity
Haiyoung Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Development of the 21-gene assay and its application in clinical practice and clinical trials
Joseph A. Sparano et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Proteomics of breast cancer: The quest for markers and therapeutic targets
Hubert Hondermarck et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer
Hailing Lu et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Reproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: A systematic review
Anne K. Callesen et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping
Keli Ou et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Targeted glycoproteomic identification of biomarkers for human breast carcinoma
Karen L. Abbott et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry
Louise Alldridge et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Identification of breast cancer peptide epitopes presented by HLA-A*0201
Oriana E. Hawkins et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS
Melinda E. Sanders et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Breast tumor microenvironment: Proteomics highlights the treatments targeting secretome
Shui-Tein Chen et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy
Julia D. Wulfkuhle et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays
Zachary S. Boyd et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
Deja vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins
Jiri Petrak et al.
PROTEOMICS (2008)
Microbiology - Desperately seeking new antibiotics
David J. Payne
SCIENCE (2008)
Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility
L. Garzia et al.
ONCOGENE (2008)
Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2
Christine E. Horak et al.
CANCER RESEARCH (2007)
Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death
Attila Stetak et al.
CANCER RESEARCH (2007)
Moving cancer diagnostics from bench to bedside
Xuewu Zhang et al.
TRENDS IN BIOTECHNOLOGY (2007)
Proteomics in human cancer research
Elzbieta Pastwa et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Proteomic profiling of 13 paired ductal infiltrating breast carcinomas and non-tumoral adjacent counterparts
Ida Pucci-Minafra et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Proteomic analysis of cancer tissues: Shedding light on carcinogenesis and possible biomarkers
Yasuhiro Kuramitsu et al.
PROTEOMICS (2006)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Differentiation of HELLP patients from healthy pregnant women by proteome analysis - On the way towards a clinical marker set
J. C. Heitner et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Differential proteome analysis of tonsils from children with chronic tonsillitis or with hyperplasia reveals disease-associated protein expression differences
T Just et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2006)
Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis
A Isidoro et al.
CARCINOGENESIS (2005)
Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells
B Willipinski-Stapelfeldt et al.
CLINICAL CANCER RESEARCH (2005)
Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns
MR Larsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells
M Salerno et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
A novel CRM1-mediated nuclear export signal governs nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase following genotoxic stress
VM Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis
A D'Angelo et al.
CANCER CELL (2004)
Proteomic signature of human cancer cells
M Seike et al.
PROTEOMICS (2004)
Phosphoglycerate mutase-derived polypeptide inhibits glycolytic flux and induces cell growth arrest in tumor cell lines
M Engel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Differential proteome analysis and mass spectrometric characterization of germ line development-related proteins of Caenorhabditis elegans
M Bantscheff et al.
PROTEOMICS (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Mass spectrometric protein structure characterization reveals cause of migration differences of haptoglobin a chains in two-dimensional gel electrophoresis
S Mikkat et al.
PROTEOMICS (2004)
Matrix-assisted laser desorption/ionization-quadrupole ion trap-time of flight mass spectrometry sequencing resolves structures of unidentified peptides obtained by in-gel tryptic digestion of haptoglobin derivatives from human plasma proteomes
C Koy et al.
PROTEOMICS (2003)
Basic and translational advances in cancer metastasis: Nm23
T Ouatas et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2003)
Expression profiling predicts outcome in breast cancer
LJ van 't Veer et al.
BREAST CANCER RESEARCH (2003)
Metastasis suppressors alter the signal transduction of cancer cells
PS Steeg
NATURE REVIEWS CANCER (2003)
Proteome analysis of diseased joints from mice suffering from collagen-induced arthritis
P Lorenz et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Metabolic cooperation between different oncogenes during cell transformation:: interaction between activated ras and HPV-16 E7
S Mazurek et al.
ONCOGENE (2001)
Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis:: role of pyruvate kinase type M2 and the glycolytic-enzyme complex
S Mazurek et al.
BIOCHEMICAL JOURNAL (2001)